-
Loading metrics
A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis
- Ann Logan,
- Zsuzsanna Nagy,
- Nicholas M. Barnes,
- Antonio Belli,
- Valentina Di Pietro,
- Barbara Tavazzi,
- Giuseppe Lazzarino,
- Giacomo Lazzarino,
- Lars Bruce,
- Lennart I. Persson
x
- Published: May 25, 2022
- https://doi.org/10.1371/journal.pone.0267183